https://hypermuscles.com/ Mon, 06 Jul 2026 04:49:20 +0000 MyBB https://hypermuscles.com/showthread.php?tid=4849 Fri, 18 Apr 2014 01:19:41 +0000 13uie67]]> https://hypermuscles.com/showthread.php?tid=4849 https://hypermuscles.com/showthread.php?tid=1394 Mon, 07 Mar 2011 06:40:59 +0000 Cornish_Celt]]> https://hypermuscles.com/showthread.php?tid=1394
CAS Name: 4-chloro-17a-methyl-17b-hydroxyandrosta-1,4-dien-3-one
Turanabol

Chlorodehydromethyltestosterone is an oral 17-alpha-alkylated steroid with a low androgenic acivity index 0.10-0.15 similar to methenolone and a myotrophic activity index of 0.50. Because of the 4-chloro alteration, chlorodehydromethyltestosterone does not convert into estrogens nor into DHT.

Chlorodehydromethyltestosterone is used in cases of muscle wasting syndrome in HIV patients. Because of it's low androgenic activity chlorodehydromethyltestosterone can be used by woman and does not cause virilization. Chlorodehydromethyltestosterone on low doses does not suppressive on hypothalamic-pituitary axis (HTPA) function.]]>
CAS Name: 4-chloro-17a-methyl-17b-hydroxyandrosta-1,4-dien-3-one
Turanabol

Chlorodehydromethyltestosterone is an oral 17-alpha-alkylated steroid with a low androgenic acivity index 0.10-0.15 similar to methenolone and a myotrophic activity index of 0.50. Because of the 4-chloro alteration, chlorodehydromethyltestosterone does not convert into estrogens nor into DHT.

Chlorodehydromethyltestosterone is used in cases of muscle wasting syndrome in HIV patients. Because of it's low androgenic activity chlorodehydromethyltestosterone can be used by woman and does not cause virilization. Chlorodehydromethyltestosterone on low doses does not suppressive on hypothalamic-pituitary axis (HTPA) function.]]> https://hypermuscles.com/showthread.php?tid=1393 Mon, 07 Mar 2011 06:40:34 +0000 Cornish_Celt]]> https://hypermuscles.com/showthread.php?tid=1393
CAS Name: (5a,17b)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol
Stanabol

Stanozolol is a17-alpha-alkylated anabolic steroid with good oral bioavailability. While stanazolol’s androgenic activity index of stanozolol is nearly the same as testosterone, its myotrophic activity is much higher at 2.0–3.7. Stanozolol does not aromatize and does not cause water retention.

Stanozolol has been used for weight loss management in HIV patients with chronic obstructive pulmonary disease and has showed significant improvement in weight, body mass index, LBM, and muscle size. Stanozolol has been shown in vitro to significantly enhance collagen synthesis. A positive effect of stanazolol on wound healing in patients with non-healing wounds has also been demonstrated. Clinical studies show that the treatment with stanozolol during the induction phase of chemotherapy results in a positive effect on the duration of cancer-free remission.]]>
CAS Name: (5a,17b)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol
Stanabol

Stanozolol is a17-alpha-alkylated anabolic steroid with good oral bioavailability. While stanazolol’s androgenic activity index of stanozolol is nearly the same as testosterone, its myotrophic activity is much higher at 2.0–3.7. Stanozolol does not aromatize and does not cause water retention.

Stanozolol has been used for weight loss management in HIV patients with chronic obstructive pulmonary disease and has showed significant improvement in weight, body mass index, LBM, and muscle size. Stanozolol has been shown in vitro to significantly enhance collagen synthesis. A positive effect of stanazolol on wound healing in patients with non-healing wounds has also been demonstrated. Clinical studies show that the treatment with stanozolol during the induction phase of chemotherapy results in a positive effect on the duration of cancer-free remission.]]> https://hypermuscles.com/showthread.php?tid=1392 Mon, 07 Mar 2011 06:40:05 +0000 Cornish_Celt]]> https://hypermuscles.com/showthread.php?tid=1392
CAS Name: 17beta-Hydroxy-1-methyl-5alpha-androst-1-en-3-one acetate
Primobol

Methenolone acetate is an oral steroid derivative of dihydrotestosterone (DHT) with a mild myotrophic activity index 0.85 and a low androgenic index 0.12. Methenolone acetate is not 17-alpha-alkylated, but 1-methylated for oral bioavailability. This reduces stress on the liver, but also this steroid's bioavailability.

It is considered one of the safer steroids, meaning it has few side effects. Because of it's low androgenic activity, methenolone acetate does not suppress endogenous testosterone secretion. Methenolone is also not overly suppressive of the HPTA axis, but will become suppressive with increased doses.]]>
CAS Name: 17beta-Hydroxy-1-methyl-5alpha-androst-1-en-3-one acetate
Primobol

Methenolone acetate is an oral steroid derivative of dihydrotestosterone (DHT) with a mild myotrophic activity index 0.85 and a low androgenic index 0.12. Methenolone acetate is not 17-alpha-alkylated, but 1-methylated for oral bioavailability. This reduces stress on the liver, but also this steroid's bioavailability.

It is considered one of the safer steroids, meaning it has few side effects. Because of it's low androgenic activity, methenolone acetate does not suppress endogenous testosterone secretion. Methenolone is also not overly suppressive of the HPTA axis, but will become suppressive with increased doses.]]> https://hypermuscles.com/showthread.php?tid=1391 Mon, 07 Mar 2011 06:39:39 +0000 Cornish_Celt]]> https://hypermuscles.com/showthread.php?tid=1391
CAS Name: (5a,17b)-17-Hydroxy-2-(hydroxymethylene)-17-methylandrostan-3-one
Oxydrol

Oxymetholone is a 17-alpha-alkylated oral anabolic-androgenic steroid. Oxymetholone is very effective in promoting muscle gains and has an excellent myotrophic activity index of 3.2 and is similar to testosterone with an androgenic activity index of 0.45. Main clinical uses include: osteoporosis, anemia, as well as stimulating muscle growth in undernourished or underdeveloped patients. Also, oxymetholone has been studied for the treatment of HIV-associated wasting, antithrombin III deficiency, pediatric growth impairment, and damaged myocardium, with varying degrees of success.]]>
CAS Name: (5a,17b)-17-Hydroxy-2-(hydroxymethylene)-17-methylandrostan-3-one
Oxydrol

Oxymetholone is a 17-alpha-alkylated oral anabolic-androgenic steroid. Oxymetholone is very effective in promoting muscle gains and has an excellent myotrophic activity index of 3.2 and is similar to testosterone with an androgenic activity index of 0.45. Main clinical uses include: osteoporosis, anemia, as well as stimulating muscle growth in undernourished or underdeveloped patients. Also, oxymetholone has been studied for the treatment of HIV-associated wasting, antithrombin III deficiency, pediatric growth impairment, and damaged myocardium, with varying degrees of success.]]> https://hypermuscles.com/showthread.php?tid=1390 Mon, 07 Mar 2011 06:39:13 +0000 Cornish_Celt]]> https://hypermuscles.com/showthread.php?tid=1390
CAS Name: (5a,17b)-17-Hydroxy-17-methyl-2-oxaandrostan-3-one
Oxanabol

Oxandrolone is a 17-alpha-alkylated oral anabolic steroid. Oxandrolone has an excellent myotrophic activity index of 3.2 and a low androgenic activity index of 0.2. At low doses, oxandrolone will not cause suppression of endogenous testosterone production and does not aromatize to estrogens.

Oxandrolone was approved for treating alcoholic hepatitis, Turner's syndrome, and weight loss caused by HIV. In addition, the drug has shown positive results in treating anemia and hereditary angioedema and for preserving muscle mass in burns patients. Oxandronolne also has been used with good success for idiopathic muscle mass loss and osteoporosis. At low dose (5-10mg), oxandrolone binds weakly to androgen receptors and therefore can be used by woman and does not cause virilisation. Oxandrolone has a half life 10-13 hours.]]>
CAS Name: (5a,17b)-17-Hydroxy-17-methyl-2-oxaandrostan-3-one
Oxanabol

Oxandrolone is a 17-alpha-alkylated oral anabolic steroid. Oxandrolone has an excellent myotrophic activity index of 3.2 and a low androgenic activity index of 0.2. At low doses, oxandrolone will not cause suppression of endogenous testosterone production and does not aromatize to estrogens.

Oxandrolone was approved for treating alcoholic hepatitis, Turner's syndrome, and weight loss caused by HIV. In addition, the drug has shown positive results in treating anemia and hereditary angioedema and for preserving muscle mass in burns patients. Oxandronolne also has been used with good success for idiopathic muscle mass loss and osteoporosis. At low dose (5-10mg), oxandrolone binds weakly to androgen receptors and therefore can be used by woman and does not cause virilisation. Oxandrolone has a half life 10-13 hours.]]> https://hypermuscles.com/showthread.php?tid=1389 Mon, 07 Mar 2011 06:38:43 +0000 Cornish_Celt]]> https://hypermuscles.com/showthread.php?tid=1389
CAS Name: (17b)-17-Hydroxy-17-methylandrosta-1,4-dien-3-one
Methanabol

Methandrostenolone is a 17-alpha-alkylated oral anabolic-androgenic steroid with anabolic properties that are more pronounced than its androgenic effects. It has little progestational activity and easily converts to estrogens. Methandrostenolone has an anabolic activity index 0.60 and an androgenic activity index 0.20. Methandrostenolone has an extra double bond in the A-ring and, therefore, is not converted by 5-alpha reduction into DHT. Since methandrostenolone was created in the 1960s, it has been used for many different applications.

At present, the only legitimate therapeutic indications for this anabolic steroid are: replacement of male sex steroids in men who have androgen deficiency, for example as a result of loss of both testes; the treatment of certain rare forms of aplastic anemia which are or may be responsive to anabolic androgens; and, in certain countries, to counteract catabolic states, for example after major trauma.]]>
CAS Name: (17b)-17-Hydroxy-17-methylandrosta-1,4-dien-3-one
Methanabol

Methandrostenolone is a 17-alpha-alkylated oral anabolic-androgenic steroid with anabolic properties that are more pronounced than its androgenic effects. It has little progestational activity and easily converts to estrogens. Methandrostenolone has an anabolic activity index 0.60 and an androgenic activity index 0.20. Methandrostenolone has an extra double bond in the A-ring and, therefore, is not converted by 5-alpha reduction into DHT. Since methandrostenolone was created in the 1960s, it has been used for many different applications.

At present, the only legitimate therapeutic indications for this anabolic steroid are: replacement of male sex steroids in men who have androgen deficiency, for example as a result of loss of both testes; the treatment of certain rare forms of aplastic anemia which are or may be responsive to anabolic androgens; and, in certain countries, to counteract catabolic states, for example after major trauma.]]> https://hypermuscles.com/showthread.php?tid=1388 Mon, 07 Mar 2011 06:38:17 +0000 Cornish_Celt]]> https://hypermuscles.com/showthread.php?tid=1388
CAS Name: (11b,17b)-9-Fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one
Halotestex

Fluoxymesterone is a 17-alpha-alkylated oral anabolic-androgenic steroid. Halogenation at position 9 increases the pharmacologic activity per unit weight compared to testosterone when given orally and reduces aromatization. It is a strong androgen with limited anabolic activity. Fluoxymesterone can be reduced by 5-alpha reductase into DHT and some of it's androgenic activity may be caused not by fluoxymesterone itself, but to its metabolite DHT.

Indication males:

Fluoxymesterone used in hypogonadal males to induce normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. Effects also include growth and maturation of prostate, seminal vesicles, penis, and scrotum; development of male hair distribution, such as beard, pubic, chest, and axillary hair; laryngeal enlargement; vocal cord thickening; alterations in body musculature; and fat distribution. Therefore, main indications for fluoxymesterolone are: primary hypogonadism (congenital or acquired) - testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy; hypogonadotropic hypogonadism (congenital or acquired) - idiopathic gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation.

Indication females:

Metastatic mammary cancer - may be used secondarily in women with advancing inoperable metastatic (skeletal) mammary cancer who are one to five years postmenopausal. Primary goals of therapy in these women include ablation of the ovaries.]]>
CAS Name: (11b,17b)-9-Fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one
Halotestex

Fluoxymesterone is a 17-alpha-alkylated oral anabolic-androgenic steroid. Halogenation at position 9 increases the pharmacologic activity per unit weight compared to testosterone when given orally and reduces aromatization. It is a strong androgen with limited anabolic activity. Fluoxymesterone can be reduced by 5-alpha reductase into DHT and some of it's androgenic activity may be caused not by fluoxymesterone itself, but to its metabolite DHT.

Indication males:

Fluoxymesterone used in hypogonadal males to induce normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. Effects also include growth and maturation of prostate, seminal vesicles, penis, and scrotum; development of male hair distribution, such as beard, pubic, chest, and axillary hair; laryngeal enlargement; vocal cord thickening; alterations in body musculature; and fat distribution. Therefore, main indications for fluoxymesterolone are: primary hypogonadism (congenital or acquired) - testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy; hypogonadotropic hypogonadism (congenital or acquired) - idiopathic gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation.

Indication females:

Metastatic mammary cancer - may be used secondarily in women with advancing inoperable metastatic (skeletal) mammary cancer who are one to five years postmenopausal. Primary goals of therapy in these women include ablation of the ovaries.]]>